Clinically Significant Thrombosis in Pediatric Heart Transplant Recipients During Their Waiting Period
Pediatric Cardiology, 08/17/2012
Law YM et al. – Clinically significant thrombosis was common in this end–stage heart failure population. Until randomized clinical trial data are available, it may be reasonable to consider anticoagulation for children admitted with decompensated heart failure and listed as UNOS status 1.